Ulrich Jaehde

The 10th annual meeting of CESAR in Essen June 28 - 30, 2012, Germany.

Ulrich Jaehde, Ralf Hilger, Thomas Gauler, 2013, International journal of clinical pharmacology and therapeutics.

Task allocation in cancer medication management - integrating the pharmacist.

Yon-Dschun Ko, Klaus Meier, Ulrich Jaehde, 2011, Patient education and counseling.

Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro.

Martin Koch, Ulrich Jaehde, U. Jaehde, 2010, International journal of pharmaceutics.

Semimechanistic Bone Marrow Exhaustion Pharmacokinetic/Pharmacodynamic Model for Chemotherapy-Induced Cumulative Neutropenia

Zinnia P. Parra-Guillen, Wilhelm Huisinga, Charlotte Kloft, 2017, The Journal of Pharmacology and Experimental Therapeutics.

A Modeling and Simulation Framework for Adverse Events in Erlotinib-Treated Non-Small-Cell Lung Cancer Patients

Thomas Zander, Martin Kocher, Sebastian Frechen, 2015, The AAPS Journal.

Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: From Scientific Evidence to Clinical Application

Ulrich Jaehde, U. Jaehde, I. Schmidt-Wolf, 2017, Scientia pharmaceutica.

The Raf kinase inhibitor BAY 43-9006 reduces cellular uptake of platinum compounds and cytotoxicity in human colorectal carcinoma cell lines

Dirk Strumberg, Dimitris Voliotis, Ulrich Jaehde, 2005, Anti-cancer drugs.

[Medication Reconciliation-theory and practice].

Ulrich Jaehde, Albrecht Eisert, Katharina Franzen, 2014, Therapeutische Umschau. Revue therapeutique.

From oncology pharmacy to pharmaceutical care: new contributions to multidisciplinary cancer care

Ulrich Jaehde, U. Jaehde, M. Westfeld, 2004, Supportive Care in Cancer.